Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the September 4, 2014, Federal Register, FDA announced its establishment of a public docket to discuss issues related to developing drugs for Duchenne Muscular Dystrophy.
United StatesFood, Drugs, Healthcare, Life Sciences
In the September 4, 2014, Federal Register,
FDA announced its establishment of a public docket to discuss
issues related to developing drugs for Duchenne Muscular Dystrophy.
FDA received a proposed draft guidance from interested parties in
June of this year and seeks additional guidance and public comment.
Comments due October 6, 2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.